Intervention not reported
Anxiety and depression in the relatives HADS (0 to 42; subscale score > 10 (range, 0 to 21) = presence of anxiety or depression) measured at 3 months and > 3 months · relatives, patients, and healthcare professionals during resucitation
1 finding from 1 review
Intervention not reported
Grief in the relatives ICG (0 to 95; > 25 = presence of complicated grief) measured at 12 months TRIG (21 to 105; lower scores indicate higher levels of grief) measured at 3 and 9 months · relatives, patients, and healthcare professionals during resucitation
1 finding from 1 review
Live birth or ongoing pregnancy · assisted reproduction technology cycles
3 findings from 1 review
Premature LH surge ‐ Own oocytes ‐ PCOS (high‐responders) ‐ Early phase stimulation protocol ‐ Frozen embryo transfer · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Live birth or ongoing pregnancy sensitivity analysis ‐ PCOS (high‐responders) ‐ own oocytes ‐ early phase stimulation protocol ‐ frozen embryo transfer (micronised progesterone 100 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in live birth or ongoing pregnancy sensitivity analysis ‐ PCOS… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Clinical pregnancy · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in clinical pregnancy ‐ Poor‐responders (MPA 10 mg versus GnRH… compared with gnRH antagonists (low certainty).
1 finding from 1 review
Live birth or ongoing pregnancy · assisted reproduction technology cycles
Summary of findings table ‐ Progestagen showed no clear difference in live birth or ongoing pregnancy compared with gnRH agonist (low certainty).
1 finding from 1 review
Clinical pregnancy · assisted reproduction technology cycles
Summary of findings table ‐ Progestagen showed no clear difference in clinical Pregnancy compared with gnRH agonist (low certainty).
1 finding from 1 review
Clinical pregnancy · assisted reproduction technology cycles
Summary of findings table ‐ Progestogen 1 showed no clear difference in clinical pregnancy ‐ Normo‐responders (MPA 10 mg versus… compared with progestogen 2 (moderate certainty).
1 finding from 1 review
Live birth or ongoing pregnancy ‐ Poor‐responders (MPA 10 mg versus GnRH antagonists) ‐ Own oocytes ‐ Early phase stimulation protocol · assisted reproduction technology cycles
Summary of findings table ‐ Progestogens showed no clear difference in live birth or ongoing pregnancy ‐ Poor‐responders (MPA 10 mg versus… compared with gnRH antagonists; GRADE not reported.
1 finding from 1 review
Cumulative pregnancy rate · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Premature LH surge ‐ Donor oocytes ‐ Normoresponders ‐ Early phase stimulation protocol ‐ Fresh embryo transfer · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Proven catheter‐related bloodstream infection (CRBSI) expressed by the authors of the individual trial as absolute rates · neonates that require central line
CHG‐IPA showed no clear difference in proven catheter‐related bloodstream infection (CRBSI) expressed by… compared with PI (low certainty).
1 finding from 1 review
Premature central line removal, defined as number of central venous catheters (CVC) removed in the trial as deemed by the author as the source of infection (premature central line removal) · neonates that require central line
CHG‐IPA showed no clear difference in premature central line removal, defined as number of central venous… compared with CHG‐A (moderate certainty).
1 finding from 1 review
Central line‐associated bloodstream infection (CLABSI) expressed using absolute rates of infants · neonates that require central line
It is very uncertain whether CHG‐IPA changes central line‐associated bloodstream infection (CLABSI) expressed… compared with PI (very low certainty).
1 finding from 1 review
Premature central line removal, defined as number of central venous catheters (CVC) removed in the trial as deemed by the author as the source of infection (premature central line removal) · neonates that require central line
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Proven catheter‐related bloodstream infection (CRBSI) expressed by the authors of the individual trial as absolute rates · neonates that require central line
CHG‐IPA showed no clear difference in proven catheter‐related bloodstream infection (CRBSI) expressed by… compared with CHG‐A (low certainty).
1 finding from 1 review
Central‐line associated bloodstream infection (CLABSI) expressed by the authors of the individual trial as absolute rates · neonates that require central line
CHG‐IPA showed no clear difference in central‐line associated bloodstream infection (CLABSI) expressed by… compared with CHG‐A (low certainty).
1 finding from 1 review
Response to treatment at 8 weeks · participants of any age with a primary diagnosis of major depressive disorder
Brexpiprazole leads to higher response to treatment at 8 weeks compared with antidepressive agents (high certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · participants of any age with a primary diagnosis of major depressive disorder
Brexpiprazole leads to higher number of dropouts due to any cause at 8 weeks compared with antidepressive agents (high certainty).
1 finding from 1 review